Correlation Between Bank of America and Helix BioPharma

Can any of the company-specific risk be diversified away by investing in both Bank of America and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank of America and Helix BioPharma Corp, you can compare the effects of market volatilities on Bank of America and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Helix BioPharma.

Diversification Opportunities for Bank of America and Helix BioPharma

-0.36

Correlation Coefficient

Bank of America  Helix BioPharma

Very good diversification

The 3 months correlation between Bank and Helix is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of Bank of America i.e., Bank of America and Helix BioPharma go up and down completely randomly.

Pair Corralation between Bank of America and Helix BioPharma

Assuming the 90 days trading horizon Bank of America is expected to generate 3.65 times less return on investment than Helix BioPharma. But when comparing it to its historical volatility, Bank of America is 4.06 times less risky than Helix BioPharma. It trades about 0.08 of its potential returns per unit of risk. Helix BioPharma Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  89.00  in Helix BioPharma Corp on December 2, 2024 and sell it today you would earn a total of  9.00  from holding Helix BioPharma Corp or generate 10.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Bank of America  vs.  Helix BioPharma Corp

Bank of America

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bank of America has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Bank of America is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Helix BioPharma Corp

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Helix BioPharma Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Helix BioPharma may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Bank of America and Helix BioPharma

The main advantage of trading using opposite Bank of America and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.

The idea behind Bank of America and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.